Showing results (531-540 of 975) with videos related to

Sort By:
Pageof 98
Maternal & Child Nutrition|May 3, 2016
Scale up of nutrition and health programs in Ethiopia and their overlap with reductions in child stuntingJames P Wirth, Joan Matji, Bradley A Woodruff, et al.
BMC Cancer|February 13, 2014
Elevated expression of prostate cancer-associated genes is linked to down-regulation of microRNAsKati Erdmann, Knut Kaulke, Cathleen Thomae, et al.
Plos One|July 23, 2016
Coverage of Adequately Iodized Salt Is Suboptimal and Rice Fortification Using Public Distribution Channels Could Reach Low-Income Households: Findings from a Cross-Sectional Survey of Anganwadi Center Catchment Areas in Telangana, IndiaJames P Wirth, Magali Leyvraz, Prahlad R Sodani, et al.
International Journal of Oncology|May 13, 2004
Quantification of disseminated tumor cells in the bloodstream of patients with hormone-refractory prostate carcinoma undergoing cytotoxic chemotherapyUta Schmidt, Udo Bilkenroth, Clemens Linné, et al.
The Journal of Urology|May 6, 2004
Systematic in vitro evaluation of survivin directed antisense oligodeoxynucleotides in bladder cancer cellsSusanne Fuessel, Bernd Kueppers, Shuangli Ning, et al.
European Urology|August 15, 2006
Perioperative complications of radical cystectomy in a contemporary seriesVladimir Novotny, Oliver W Hakenberg, Diana Wiessner, et al.
World Journal of Urology|December 15, 2015
Age, American Society of Anesthesiologists physical status classification and Charlson score are independent predictors of 90-day mortality after radical cystectomyVladimir Novotny, Michael Froehner, Rainer Koch, et al.
European Urology Open Science|August 2, 2021
Decreasing Non-bladder-cancer Mortality After Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
International Journal of Oncology|June 16, 2001
Human telomerase reverse transcriptase antisense treatment downregulates the viability of prostate cancer cells in vitroA Schindler, U Fiedler, A Meye, et al.
Urologia Internationalis|June 17, 2020
Validation of a Questionnaire-Suitable Comorbidity Index in Patients Undergoing Radical CystectomyMichael Froehner, Rainer Koch, Ulrike Heberling, et al.
Pageof 98